As they say, it can be lonely at the top. Leadership isn’t always easy or obvious. While the importance of consensus-building and the invaluable insights garnered from diverse perspectives both within ...

An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will undertake a study to assess options presented in the document Options for Consideration of Chronic Disease ...

The FDA and EMA have aligned on ten guiding principles for the responsible use of artificial intelligence across the drug development lifecycle, establishing a shared framework to support innovation, ...